KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Gains from Investment Securities (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Gains from Investment Securities for 6 consecutive years, with $19000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities rose 11.76% year-over-year to $19000.0, compared with a TTM value of $52000.0 through Sep 2025, down 49.51%, and an annual FY2024 reading of $50000.0, down 41.86% over the prior year.
  • Gains from Investment Securities was $19000.0 for Q2 2025 at Clover Health Investments, down from $33000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $134.5 million in Q2 2021 and bottomed at -$200.8 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is -$8.2 million, with a median of $59500.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 134612.0% in 2021, while the deepest fall reached 729.28% in 2021.
  • Year by year, Gains from Investment Securities stood at -$200.8 million in 2021, then surged by 100.32% to $648000.0 in 2022, then plummeted by 86.73% to $86000.0 in 2023, then crashed by 61.63% to $33000.0 in 2024, then crashed by 42.42% to $19000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CLOV at $19000.0 in Q2 2025, $33000.0 in Q4 2024, and $17000.0 in Q2 2024.